Intrathecal expression of proteins regulating apoptosis in acute stroke

Stroke

Volumn 30, Issue 2, 1999, Pages 321-327

  Tarkowski, Elisabeth ^a,b   Rosengren, L ^a   Blomstrand, C ^a   Jensen, C ^a   Ekholm, S ^a   Tarkowski, A ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b Depts Rheumatology Clin Immunol   (Sweden)

Author keywords

Apoptosis; Brain; Cerebrospinal fluid; Cytokines; Magnetic resonance imaging; Proteins; Stroke

Indexed keywords

CYTOKINE; FAS ANTIGEN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; APOPTOSIS; ARTICLE; CELL DEATH; CEREBROSPINAL FLUID ANALYSIS; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; MALE; NEUROLOGIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTEIN EXPRESSION; STROKE;

EID: 0032948710     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.30.2.321     Document Type: Article

References (40)

1. Kogure K, Kato H. Neurochemistry of stroke. In: Barnett HJM, Mohr JP, Stein BM, Yatsu FM, eds. Stroke: Pathophysiology, Diagnosis, and Management. 2nd ed. New York, NY: Churchill Livingstone; 1992:3-28.
2. Siesjö BK. A new perspective on ischemic brain damage? Prog Brain Res. 1993;96:1-12.
3. Diemer NH, Valente E, Bruhn T, Berg M, Jörgensen MB, Johansen FF. Glutamate receptor transmission and ischemic nerve cell damage: evidence for involvement of excitotoxic mechanisms. Prog Brain Res. 1993;96:105-124.
4. Watson BD. Evaluation of the concomitance of lipid peroxidation in experimental models of cerebral ischemia and stroke. Prog Brain Res. 1993;96:69-96.
5. Kochanek PM, Hallenbeck JM. Polymorphonuclear leukocytes and monocytes/macrophages in the pathogenesis of cerebral ischemia and stroke. Stroke. 1992;23:1367-1379.
6. Lindsberg PJ, Carpen O, Paetau A, Karjalainen-Lindsberg M-J, Kaste M. Endothelial ICAM-1 expression associated with inflammatory cell response in human ischemic stroke. Circulation. 1996;94:939-945.
7. Chalmers-Redman RME, Fraser AD, Ju WYH, Wadia J, Tatton NA, Tatton WG. Mechanisms of nerve cell death: apoptosis or necrosis after cerebral ischemia. In: Green AR, Cross AJ, eds. Neuroprotective Agents and Cerebral Ischemia. San Diego, Calif: Academic Press; 1997:1-25.
8. Nagata S, Golstein P. The Fas death factor. Science. 1995;267: 1449-1456.
9. Cheng J, Zhou T, Liu C, Shapiro JP, Brauer MJ, Kiefer MC, Barr PJ, Mountz JD. Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule. Science. 1994;263:1759-1762.
10. Kagi D, Vignaux F, Lederman B, Burki K, Depraetere V, Nagata S, Hengartner H, Golstein P. Fas and perform pathways as major mechanisms of T cell-mediated cytotoxicity. Science. 1994;265:528-530.
11. Liles WC, Kiener PA, Ledbetter JA, Aruffo A, Klebanoff SJ. Differential expression of Fas (CD95) and Fas ligand on normal human phagocytes: implications for the regulation of apoptosis in neutrophils. J Exp Med. 1996;184:429-440.
12. Matsuyama T, Hata R, Yamamoto Y, Tagaya M, Akita H, Uno H, Wanaka A, Furuyama J-I, Sugita M. Localization of Fas antigen mRNA induced in postischemic murine forebrain by in situ hybridization. Mol Brain Res. 1995;34:166-172.
13. Linnik MD, Zobrist RH, Hatfield MD. Evidence supporting a role for programmed cell death in focal cerebral ischemia in rats. Stroke. 1993; 24:2002-2009.
14. Hockenberry D, Nunez G, Milliman C, Schreiber R, Korsmeyer S. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature. 1990;348:334-336.
15. Borner C, Martinou I, Mattmann, C, Irmler M, Schaerer E, Martinou J-C, Tschopp J. The protein bcl-2a does not require membrane attachment, but two conserved domains to suppress apoptosis. J Cell Biol. 1994;126: 1059-1068.
16. Allsopp TE, Wyatt A, Paterson HF, Davies AM. The protooncogene bcl-2 can selectively rescue neurotrophic-factor dependent neurons from apoptosis. Cell. 1993;73:295-307.
17. Martinou J, Dubois-Dauphin M, Staple J, Frankowski H, Missotten M, Albertini P, Talabot D, Catsicas S, Pietra C. Overexpression of bcl-2 in transgenic mice protects neurons from naturally occurring death and experimental ischemia. Neuron. 1994;13:1017-1030.
18. Linnik MD, Zahos P, Geschwind MD, Federoff HJ. Expression of bcl-2 from a defective herpes simplex virus-1 limits neuronal death in focal cerebral ischemia. Stroke. 1995;26:1670-1675.
19. Aliprantis AO, Diez-Roux G, Mulder LCF, Zychlinsky A, Lang RA. Do macrophages kill through apoptosis? Immunol Today. 1996;17:573-576.
20. Chopp M, Li Y, Jiang N, Zhang RL, Prostak J. Antibodies against adhesion molecules reduce apoptosis after middle cerebral artery occlusion in rat brain. J Cereb Blood Flow Metab. 1996;16:578-584.
21. Tarkowski E, Rosengren L, Blomstrand C, Wikkelsö C, Jensen C, Ekholm S, Tarkowski A. Early intrathecal production of interleukin-6 predicts the size of brain lesion in stroke. Stroke. 1995;26:1393-1398.
22. Tarkowski E, Rosengren L, Blomstrand C, Wikkelsö C, Jensen C, Ekholm S, Tarkowski A. Intrathecal release of pro- and antiinflammatory cytokines in stroke. Clin Exp Immunol. 1997;110:492-499.
23. Scandinavian Stroke Study Group. Multicenter trial of hemodilution in ischemic stroke: background and study protocol. Stroke. 1985;16: 885-890.
24. Mahoney FI, Barthel DW. Functional evaluation: the Barthel Index. Md State Med J. 1965;24:61-69.
25. Hachinski V. Classification of stroke for clinical trials. Stroke. 1990;21: 27-29.
26. Blomstrand C, Olsson JE, Nilsson B, von Arbin M, Britton M, Elwin CE, Elmers C, Norrving B, Rosen A, Samuelsson K, Strandberg K, Wahlgren NG. Swedish Aspirin Low-dose Trial (SALT) of 75 mg aspirin as secondary prophylaxis after cerebrovascular ischaemic events. Lancet. 1991; 338:1345-1349.
27. Landorp PM, Aarden LA, Calafat J, Zeijlemaker WP. A growth factor dependent B-cell hybridoma. Curr Top Microbiol Immunol. 1986;132: 105-113.
28. Aarden LA, de Groot ER, Shaap OL, Lansdorp PM. Production of hybridoma growth factor by human monocytes. Eur J Immunol. 1987; 17:1411-1416.
29. Helle M, Boeije L, Aarden LA. Functional discrimination between interleukin-6 and interleukin-1. Eur J Immunol. 1988;18:1535-1540.
30. Kretschmann H-J, Weinrich V. Cranial Neuroimaging and Clinical Anatomy. 2nd ed. Stuttgart, Germany: Thieme; 1992:1-100.
31. Bariniga M. Stroke-damaged neurons may commit cellular suicide. Science. 1998;281:1302-1303.
32. Ertel W, Keel M, Stocker R, Imhof H-G, Leist M, Steckholzer U, Tanaka M, Trentz O, Nagata S. Detectable concentrations of Fas ligand in cerebrospinal fluid after severe head injury. J Neuroimmunol. 1997;80: 93-96.
33. Itoh N, Tsujimoto Y, Nagata S. Effect of bcl-2 on Fas antigen mediated cell death. J Immunol. 1993;151:621-627.
34. Takayama S, Sato T, Krajewskj S, Kochel K, Trie S, Millan JA, Reed JC. Cloning and functional analysis of BAG-1: a novel bcl-2-binding protein with anti-cell death activity. Cell. 1995;80:279-284.
35. Voll ER, Hermann M, Roth EA, Stach C, Kalden JR. Immunosuppressive effects of apoptotic cells. Nature. 1997;390:350-351.
36. Holmin S. Inflammation in Brain Contusion [thesis]. Stockholm, Sweden: Stockholm University; 1997.
37. Cheng B, Christakos S, Mattson MP. Tumor necrosis factors protect neurons against metabolic-excitotoxic insults and promote maintenance of calcium homeostasis. Neuron. 1994;12:139-153.
38. Schwartz M, Solomon A, Lavie V, Ben BS, Belkin M, Cohen A. Tumor necrosis factor facilitates regeneration of injured central nervous system axons. Brain Res. 1991;545:334-338.
39. 2+ accumulation. Proc Natl Acad Sci U S A. 1995;92:9328-9332.
40. Tarkowski E, Blennow K, Wallin A, Tarkowski A. Intracerebral production of tumor necrosis factor-α in Alzheimer disease and vascular dementia. J Neuroimmunol. 1998;90:31. Abstract.